Reactions

Reactions

Reactions

When science hits the headlines, we seek the views of expert sources who assess the news rigorously and quickly, according to the available evidence.

Reaction to method that could predict Alzheimer's risk before symptoms appear

Scientists have analysed data on 7.1 million common DNA variants (alterations in the standard sequence) in people with and without Alzheimer's disease. The results, published in PLOS Genetics, have helped them to develop a method that can predict the risk of suffering from this neurodegenerative disease, depending on the DNA variants that a person has and before presenting symptoms.

Reactions to study claiming three doses of covid-19 vaccines protect better than two

To estimate the effectiveness of two or three doses of vaccines against covid-19 infection and hospitalisation, researchers in Denmark conducted a study of all previously uninfected Danish residents aged 12 years and older. The conclusion of the research, which is published in PLOS Medicine, is that a third dose provided greater protection against infection and hospitalisation with omicron than two vaccines.

Reaction to study concluding that drinking black tea may be associated with lower mortality risk

Using data from the UK Biobank, where black tea consumption is common, researchers have examined whether its intake is associated with a lower risk of mortality. Participants who reported drinking two or more cups a day had a 9-13% lower mortality risk compared to non-tea drinkers. The results are published in the Annals of Internal Medicine.

Reaction to study claiming that the frequency of heatwaves will increase this century

Research estimates that the rise in global average temperatures could approach 2 ˚C by 2050. The study, published in Communications Earth and Environment, estimates that by 2100 many people living in tropical regions will be exposed to dangerously high levels of heat on most days of the year. In addition, deadly heatwaves, which are currently rare in mid-latitudes, could occur every year in these areas.

Reaction to the study analysing the effectiveness of Paxlovid against the omicron variant

A study published in the New England Journal of Medicine has analysed the effectiveness of the antiviral drug Paxlovid after implantation of the omicron variant. The relative risk of severe disease decreased markedly in patients over 65 years of age, both vaccinated and unvaccinated. No differences were found in those under 65 years of age.